A. Kluska

发表

Whole‐exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype

M. Mikuła, J. Ostrowski, A. Paziewska, 2018, Liver international : official journal of the International Association for the Study of the Liver.

GWAS links variants in neuronal development and actin remodeling related loci with pseudoexfoliation syndrome without glaucoma

E. Hennig, A. Paziewska, A. Kluska, 2017, Experimental eye research.

Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population

M. Mikuła, J. Ostrowski, A. Rybak, 2015, PloS one.

Changes in BRCA 1 gene in patients with familial breast cancer in the Warsaw region of Poland

A. Kluska, B. Konopka, A. Janiec-Jankowska, 2004 .

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

M. Dąbrowska, A. Kluska, A. Bałabas, 2012, Familial Cancer.

Genetic associations with lymphomas in Polish patients: A pooled‐DNA genome‐wide association analysis

M. Mikuła, J. Ostrowski, A. Paziewska, 2022, International journal of immunogenetics.

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma

M. Mikuła, J. Ostrowski, P. Rutkowski, 2018, Journal of Cancer.

Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer

J. Ostrowski, P. Gaj, M. Dąbrowska, 2013, Familial Cancer.

A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.

M. Mikuła, J. Ostrowski, A. Kluska, 2018, Blood transfusion = Trasfusione del sangue.

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing

M. Mikuła, J. Ostrowski, A. Paziewska, 2015, BMC Medical Genomics.

High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer

J. Ostrowski, P. Gaj, M. Dąbrowska, 2012, Familial Cancer.

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

M. Dąbrowska, A. Kluska, A. Bałabas, 2012, Familial Cancer.

Prevalence of the most frequent BRCA1 mutations in Polish population

Danuta Januszkiewicz-Lewandowska, M. Dąbrowska, A. Kluska, 2011, Journal of Applied Genetics.

Age at Onset of Bilateral Breast Cancer, the Presence of Hereditary BRCA1, BRCA2, CHEK2 Gene Mutations and Positive Family History of Cancer

M. Dąbrowska, A. Kluska, A. Bałabas, 2009, Oncology Research and Treatment.

Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland

A. Kluska, M. Piątkowska, D. Nowakowska, 2006, International journal of cancer.

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing

M. Mikuła, J. Ostrowski, A. Paziewska, 2015, BMC Medical Genomics.

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

M. Dąbrowska, A. Kluska, A. Dansonka-Mieszkowska, 2010, BMC Medical Genetics.

Mutational landscape of primary and recurrent Ewing sarcoma

M. Mikuła, P. Rutkowski, A. Kluska, 2021, Contemporary oncology.

Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs

M. Mikuła, J. Ostrowski, P. Rutkowski, 2021, BioMed research international.

Signatures of circulating microRNA in four sarcoma subtypes

M. Mikuła, J. Ostrowski, P. Rutkowski, 2020, Journal of Cancer.

Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population

M. Mikuła, J. Ostrowski, A. Paziewska, 2016, Scientific Reports.

Epidermal Growth Factor Receptor and Estrogen and Progesterone Receptors in Breast Cancers of Premenopausal and Postmenopausal Patients

A. Kluska, B. Bielińska, E. Skasko, 1994, Tumori.

Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases

M. Mikuła, J. Ostrowski, A. Paziewska, 2018, Journal of Crohn's & colitis.

GWAS Links New Variant in Long Non-Coding RNA LINC02006 with Colorectal Cancer Susceptibility

J. Ostrowski, E. Hennig, A. Kluska, 2021, Biology.

Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases

M. Mikuła, J. Ostrowski, K. Mucha, 2019, Scientific Reports.

Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology

M. Mikuła, J. Ostrowski, M. Dębska, 2022, Transfusion.

Relationships between the concentrations of epidermal growth factor, insulin-likegrowth factor-I, estrogens and progesterone receptors in women breast cancer,and the histologic type of tumor and its grade of malignancy

A. Kluska, W. Olszewski, E. Skasko, 2002 .

PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland

M. Mikuła, J. Ostrowski, A. Kluska, 2017, BMC Medical Genomics.

Prediction of fetal blood group and platelet antigens from maternal plasma using next‐generation sequencing

M. Mikuła, J. Ostrowski, M. Dębska, 2019, Transfusion.

Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer

M. Mikuła, J. Ostrowski, A. Paziewska, 2020, Diagnostics.

Non-CYP2D6 Variants Selected by a GWAS Improve the Prediction of Impaired Tamoxifen Metabolism in Patients with Breast Cancer

J. Ostrowski, E. Hennig, A. Paziewska, 2019, Journal of clinical medicine.

Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer

J. Ostrowski, E. Hennig, M. Dadlez, 2015, BMC Cancer.

Exome sequencing to explore the possibility of predicting genetic susceptibility to the joint occurrence of polycystic ovary syndrome and Hashimoto’s thyroiditis

E. Hennig, A. Kluska, M. Kulecka, 2023, Frontiers in immunology.

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection

M. Mikuła, J. Ostrowski, M. Dąbrowska, 2023, Frontiers in cellular and infection microbiology.

Characteristics of the gut microbiome in esports players compared with those in physical education students and professional athletes

M. Mikuła, J. Ostrowski, A. Kluska, 2023, Frontiers in Nutrition.

PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland

M. Mikuła, J. Ostrowski, A. Kluska, 2017, BMC Medical Genomics.

High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer

J. Ostrowski, P. Gaj, M. Dąbrowska, 2012, Familial Cancer.

Preliminary studies on DNA retardation by MutS applied to the detection of point mutations in clinical samples.

P. Sachadyn, J. Kur, A. Kluska, 2005, Mutation research.

A. Kluska, W. Olszewski, E. Skasko, 2002 .

Breast cancer but not the menopausal status is associated with small changes of the gut microbiota

M. Mikuła, M. Dąbrowska, A. Kluska, 2024, Frontiers in oncology.

Effects of Soluble Dextrin Fiber from Potato Starch on Body Weight and Associated Gut Dysbiosis Are Evident in Western Diet-Fed Mice but Not in Overweight/Obese Children

Z. Kułaga, M. Dąbrowska, A. Kluska, 2024, Nutrients.

Dysbiosis of the Upper Gastrointestinal Tract in Head-and-Neck Cancer Survivors: A Pilot Study Using the Capsule Sponge Device

M. Dąbrowska, A. Kluska, M. Kulecka, 2024, Cancers.